New products
ADA26: Dexcom’s G7 CGM helps TD2 diabetics not on insulin manage glucose levels
Dexcom presented data on its G7 continuous glucose monitoring system showing efficacy in type 2 diabetes patients not requiring insulin therapy. The company expects the findings may influence clinical practice patterns for this patient population.
The source
This brief is a MedIndexer summary of reporting by Medical Device Network. To read the full story, head to the source.
Read the full story at Medical Device Network